Ionis Pharmaceuticals
IONS
IONS
303 hedge funds and large institutions have $5.6B invested in Ionis Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 97 increasing their positions, 110 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 311 → 303 (-8)
12% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 110
20% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 41
Holders
303
Holding in Top 10
5
Calls
$21.6M
Puts
$23.6M
Top Buyers
| 1 | +$81.3M | |
| 2 | +$42.8M | |
| 3 | +$37.5M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$34.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$23.6M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$13M | |
| 3 | -$10.9M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.7M |
| 5 |
Goldman Sachs
New York
|
-$9.59M |